JCN Network - Home
JCN Newswire
 Search:    Companies  | Annual Reports  |  CSR  | News Alerts  |  Japanese   
Company
News Sectors
Automotive
Chemicals
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Tech
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
Trade Shows
News Alerts
News Search
Photo Gallery
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
Bookmark and Share
FANCL Announces Research Results of Antiaging Material Silybin at IFSCC International Conference 2005
 

Tokyo, Oct 5, 2005 (JCN) - Japanese cosmetic manufacturer FANCL announced on September 29 that it has presented research results of silybin, an extract derived from milk thistle seeds, at the International Federation of Societies of Cosmetics Chemists (IFSCC) International Conference 2005 held in Italy, from September 19 to 21.

The company's Central Research Laboratory made presentations under the title "Anti-aging effect of silybin, a flavonoid isolated from Silybum marianum".

Specifically, the presentations cited that silybin has properties to improve and suppress wrinkles, inhibit the skin aging and improve the photoaged skin.

By Dale Hug Staff Writer

Copyright © 2010 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  FANCL  News  RSS  
  FANCL to Introduce New Additive-free Hair Care Series in June  (Apr 21, 2006)
  FANCL Releases FANCL CLINICAiD, Nutritional Supplement Series Targeted at Medical Institutions  (Feb 15, 2006)
  FANCL Announces Anti-atopic Dermatitis Effect of Kale Juice at Recent Academic Meeting  (Dec 13, 2005)
  FANCL to Bring to Market New Antiaging Supplement in December  (Oct 6, 2005)
  FANCL Announces Research Results of Antiaging Material Silybin at IFSCC International Conference 2005  (Oct 5, 2005)
  FANCL's New Alpha Lipoic Acid-based Supplement to Go on Sale  (June 1, 2005)
  FANCL, Hiroshima Prefectural University Confirm Anti-wrinkle and Skin Cell Protection Effects of Silymarin, Milk Thistle-derived Extract  (June 1, 2005)
  FANCL Confirms that Secondhand Smoke Exposure Affects Dogs, Antioxidant Supplements Good for Those Affected Dogs  (May 19, 2005)
  FANCL Confirms Brown Rice Properties Against Diabetic Nephropathy  (May 18, 2005)
  FANCL Confirms Positive Effects of Long-term Intake of Germinated Brown Rice Against Diabetic Nephropathy  (May 16, 2005)



 Recent  Health/Medical News   RSS  
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)

More Health/Medical news...

 Recent  Health/Medical News   RSS  
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)

More Health/Medical news...
 
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)